BARK trades 198.8% below Wall Street's consensus target of $30.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes BARK achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, BARK, Inc. (BARK) has a Wall Street consensus price target of $30.00, based on estimates from 4 covering analysts. With the stock currently trading at $10.04, this represents a potential upside of +198.8%. The company has a market capitalization of $87M.
Analyst price targets range from a low of $30.00 to a high of $30.00, representing a 0% spread in expectations. The median target of $30.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, BARK trades at a trailing P/E of -2.2x. Analysts expect EPS to grow +44.2% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CHWYChewy, Inc. | $8.6B | $20.73 | $31.54 | +52.1% | Buy | 26.3x | 38 |
FRPTFreshpet, Inc. | $2.7B | $54.51 | $77.33 | +41.9% | Buy | 30.7x | 29 |
WOOFPetco Health and Wellness Company, Inc. | $722M | $2.53 | $3.46 | +36.8% | Hold | 17.3x | 25 |
HIMSHims & Hers Health, Inc. | $7.9B | $36.17 | $28.69 | -20.7% | Hold | — | 20 |
PSFEPaysafe Limited | $418M | $8.08 | $10.13 | +25.4% | Buy | 3.7x | 11 |
OLPXOlaplex Holdings, Inc. | $1.4B | $2.07 | $1.89 | -8.7% | Hold | 24.0x | 14 |
MNSTMonster Beverage Corporation | $94.8B | $96.92 | $90.58 | -6.5% | Buy | 42.2x | 44 |
AMZNAmazon.com, Inc. | $2.6T | $245.98 | $307.77 | +25.1% | Buy | 27.9x | 94 |
WMTWalmart Inc. | $889.1B | $111.54 | $139.44 | +25.0% | Buy | 38.4x | 66 |
TGTTarget Corporation | $59.2B | $130.29 | $136.80 | +5.0% | Buy | 15.5x | 60 |
Quick answers to the most common questions about buying BARK stock.
The consensus Wall Street price target for BARK is $30, representing 198.8% upside from the current price of $10.04. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
BARK has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $30 implies 198.8% upside from current levels.
BARK's current price is $10.04 with a consensus target of $30 (198.8% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $30 for BARK, while the most conservative target is $30. The consensus of $30 represents the median expectation. These targets typically reflect 12-month expectations.
BARK is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BARK stock forecast based on 4 Wall Street analysts shows a consensus price target of $30, with estimates ranging from $30 (bear case) to $30 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on BARK, with a "Buy" consensus rating and $30 price target (198.8% upside). 3 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BARK analyst price targets range from $30 to $30, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $30 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.